October 17, 2019
  • October 17, 2019
Breaking News

Tag Archives

Draper signed a tissue model development deal with Bristol-Myers Squibb Company (NYSE:BMY)

by on July 1, 2019 0
Draper, based in Cambridge, Massachusetts, signed a tissue model development deal with Bristol-Myers Squibb Company (NYSE:BMY). The companies will collaborate on developing a unique liver tissue model to screen drugs for toxicity. Draper will use its Human Organ Systems (HOS) platform to generate a liver model for Bristol-Myers Squibb to perform toxicity testing. The stock... Read More

Don’t Miss: American Airlines Group Inc. (NASDAQ:AAL), Bristol-Myers Squibb Company (NYSE:BMY), Geron Corporation (NASDAQ:GERN), WEC Energy Group, Inc. (NYSE:WEC)

by on June 28, 2019 0
A U.S. appeals court has ruled that American Airlines Group Inc. (NASDAQ:AAL) was not required to allow a communications specialist with multiple sclerosis to continue working from home, as she had done for years, when it reorganized after a merger. The 7th U.S. Circuit Court of Appeals in a 2-1 decision on Wednesday said... Read More

FDA granted Orphan Drug Designation for Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) lead product

by on June 28, 2019 0
Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) said the FDA has granted Orphan Drug Designation for its lead product candidate ARCT-810 to treat ornithine transcarbamylase deficiency – the most common urea cycle disorder that makes it difficult for the removal of toxic waster products as proteins are digested. Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT), a Financial sector... Read More

Healthcare Mover: Acasti Pharma Inc. (NASDAQ:ACST), Pfizer Inc. (NYSE:PFE), Bristol-Myers Squibb Company (NYSE:BMY)

by on June 27, 2019 0
Acasti Pharma Inc. (NASDAQ:ACST) loss for fiscal 2019 expanded from $21.5 million in the prior year to $51.6 million due to higher R&D costs for the TRILOGY Phase 3 program and other financial expenses. The company ended the year with $34.4 million in cash $26.2 million more than than the prior year on the basis of net proceeds from... Read More

NIKE, Inc. (NYSE:NKE) releases its new NikeCourt London 2019 collection

by on June 26, 2019 0
NIKE, Inc. (NYSE:NKE) releases its new NikeCourt London 2019 collection today, a unique take on traditional tennis whites with a mix of textured piece in both classic while and a bold black colourway. The collection creates a tactile experience for players with its mix of textures, using mainly knitted fabrics to craft sweaters, cardigans and more vintage-inspired piece... Read More

Bristol-Myers Squibb Company (NYSE:BMY) provided update on approval process with Celgene Corporation

by on June 25, 2019 0
Bristol-Myers Squibb Company (NYSE:BMY) provided an update on the approval process and timeline for the Company’s pending merger with Celgene Corporation. The Company remains actively engaged in discussions with the U.S. Federal Trade Commission (“FTC”) on the FTC’s continued review of the proposed transaction. To allow the transaction to close on a timely basis in light... Read More